Christopher Mann – New Scientific and Regulatory Affairs Director

por Asphalion

3 years ago
Christopher Mann, Biochemistry, gene therapy, muscular dystrophy

Asphalion’s Board of Directors is pleased to announce the appointment of Christopher Mann as new Scientific and Regulatory Affairs Director.

WHITE PAPER | The EU Regulatory Environment of Medical Devices Software Development

por Asphalion

3 years ago
New Medical Devices Software, MDSW, medical devices

New Medical Devices Software (MDSW) should be developed in Europe in accordance with the requirements of the new legislative framework given by REGULATION (EU) 2017/745 on medical devices (hereinaf...

Dominique Monferrer – New Medical Devices Director

por Asphalion

3 years ago
Dominique Monferrer, Medical Devices, Asphalion, technologies, in vitro diagnostics

Asphalion’s Board of Directors is pleased to announce the appointment of Dominique Monferrer as new Medical Devices Director.

BREXIT | Procedures for UK PIPs in case of a no-deal Brexit

por Asphalion

3 years ago
Brexit, UK, Medicines, Healthcare products

The United Kingdom (UK) has left the European Union (EU) and the transition period after Brexit comes to an end this year and from 1 January 2021 new regulations will apply. These changes will also af...

Asphalion celebrates 15,000 followers on LinkedIn!

por Asphalion

3 years ago
Medical Devices, Regulatory Affairs, Asphalion, followers, Linkedin, Brexit

Today is an exciting day for Asphalion as we have reached 15,000 followers on LinkedIn!

Schedule a meeting with us!

por Asphalion

3 years ago
meeting, drug, regulatory affairs

Are you developing a drug and need help with regulatory affairs?

Today is World AIDS Day – Thanks to everyone working to end AIDS!

por Asphalion

3 years ago
AIDS, HIV, health, antiretroviral therapy, HIVACAR

Today is World AIDS Day and we would like to take this opportunity to increase the awareness on this disease and to thank everyone working tirelessly to end AIDS.

Workshop on support for orphan medicines development by EMA

por Asphalion

3 years ago
orphan medicines, EMA, drugs development, Stakeholders

Today, Montse de Castellarnau, Scientific & Regulatory Affairs Officer at Asphalion, will be attending the “Workshop on support for orphan medicines development”. The workshop is organized by the ...

Barcelona Innovation Day/ London 2020

por Asphalion

3 years ago
Innovation Day, stakeholders, best practices, innovation, talent

The Barcelona Innovation Day/ London 2020 is a high-level forum that will bring together the most prominent stakeholders from academia, start-ups, industry, and public institutions from Barcelona and ...

Asphalion receives medal for sustainability from EcoVadis

por Asphalion

3 years ago
sustainability, EcoVadis, supply chains, Asphalion

Asphalion is proud to announce that it has been awarded a medal for Corporate Social Responsibility from EcoVadis, the world’s most trusted provider of business sustainability ratings, intelligence,...

eSUBManager – Nueva herramienta desarrollada por Extedo

por Asphalion

4 years ago
eSUBManager, Extedo, secuencias

Asphalion presenta eSUBManager, una herramienta desarrollada por Extedo que en conexión con el eCTDManager permite, entre otras funciones:

Why is it so important to encourage people to notify adverse drug reactions?

por Asphalion

4 years ago
notify, drug reactions, MedSafetyWeek, Pharmacovigilance

Last week (2nd – 8th of November, 2020), the MedSafetyWeek was held. This initiative is a social media campaign organised by the Uppsala Monitoring Centre (UMC), the World Health Organization (WHO) ...